India · Delayed Price · Currency is INR Veerhealth Care Statistics
Total Valuation
Veerhealth Care has a market cap or net worth of INR 554.16 million. The enterprise value is 595.33 million.
| Market Cap | 554.16M |
| Enterprise Value | 595.33M |
Important Dates
The last earnings date was Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Veerhealth Care has 20.00 million shares outstanding. The number of shares has increased by 0.75% in one year.
| Current Share Class | 20.00M |
| Shares Outstanding | 20.00M |
| Shares Change (YoY) | +0.75% |
| Shares Change (QoQ) | +2.57% |
| Owned by Insiders (%) | 43.61% |
| Owned by Institutions (%) | 3.51% |
| Float | 11.17M |
Valuation Ratios
The trailing PE ratio is 102.63.
| PE Ratio | 102.63 |
| Forward PE | n/a |
| PS Ratio | 1.66 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.22 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 109.44 |
| EV / Sales | 1.79 |
| EV / EBITDA | 18.25 |
| EV / EBIT | 30.22 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.37 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | -6.89 |
| Interest Coverage | 4.90 |
Financial Efficiency
Return on equity (ROE) is 2.41% and return on invested capital (ROIC) is 3.15%.
| Return on Equity (ROE) | 2.41% |
| Return on Assets (ROA) | 3.16% |
| Return on Invested Capital (ROIC) | 3.15% |
| Return on Capital Employed (ROCE) | 6.41% |
| Weighted Average Cost of Capital (WACC) | 5.42% |
| Revenue Per Employee | 8.32M |
| Profits Per Employee | 136,000 |
| Employee Count | 40 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 7.01 |
Taxes
In the past 12 months, Veerhealth Care has paid 7.14 million in taxes.
| Income Tax | 7.14M |
| Effective Tax Rate | 56.75% |
Stock Price Statistics
The stock price has increased by +47.93% in the last 52 weeks. The beta is 0.24, so Veerhealth Care's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +47.93% |
| 50-Day Moving Average | 22.31 |
| 200-Day Moving Average | 19.63 |
| Relative Strength Index (RSI) | 85.35 |
| Average Volume (20 Days) | 145,136 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Veerhealth Care had revenue of INR 332.86 million and earned 5.44 million in profits. Earnings per share was 0.27.
| Revenue | 332.86M |
| Gross Profit | 91.36M |
| Operating Income | 19.70M |
| Pretax Income | 12.58M |
| Net Income | 5.44M |
| EBITDA | 32.62M |
| EBIT | 19.70M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 4.58 million in cash and 45.75 million in debt, with a net cash position of -41.17 million or -2.06 per share.
| Cash & Cash Equivalents | 4.58M |
| Total Debt | 45.75M |
| Net Cash | -41.17M |
| Net Cash Per Share | -2.06 |
| Equity (Book Value) | 229.23M |
| Book Value Per Share | 11.67 |
| Working Capital | 50.30M |
Cash Flow
In the last 12 months, operating cash flow was 41.91 million and capital expenditures -48.55 million, giving a free cash flow of -6.65 million.
| Operating Cash Flow | 41.91M |
| Capital Expenditures | -48.55M |
| Depreciation & Amortization | 12.91M |
| Net Borrowing | -3.33M |
| Free Cash Flow | -6.65M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 27.45%, with operating and profit margins of 5.92% and 1.63%.
| Gross Margin | 27.45% |
| Operating Margin | 5.92% |
| Pretax Margin | 3.78% |
| Profit Margin | 1.63% |
| EBITDA Margin | 9.80% |
| EBIT Margin | 5.92% |
| FCF Margin | n/a |
Dividends & Yields
Veerhealth Care does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.75% |
| Shareholder Yield | -0.75% |
| Earnings Yield | 0.98% |
| FCF Yield | -1.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 22, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 22, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |